Study on compare of sublingual, rectal and vaginal misoprostol for cervical priming 12 hours before hysteroscopy

Not Applicable

• Conditions: Condition 1: Patients who are candidates for hysteroscopy. Condition 2: Patients who are candidates for hysteroscopy.; Noninflammatory disorder of uterus, unspecified; Inflammatory disease of uterus, unspecified

• Registration Number: IRCT201105296626N1
• Lead Sponsor: Tabriz University of medical science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

All the patients who need diagnostic hysteroscopy and surgery such as: irregular uteral bleeding; inter uteral lesions in hysterosalpangography or sonography.
Exclusion criteria: pregnancy; urinary tract infection; history of previous cervix surgery; cervix failure; patient dissatisfaction and prohibition prostaglandin intake

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cervix dilation for hysteroscopy. Timepoint: During hysteroscopy. Method of measurement: Hegar.

Secondary Outcome Measures

Name	Time	Method
Reduce hysteroscopy's complications. Timepoint: After hysteroscopy. Method of measurement: By examination.;Reduce pain during hysteroscopy. Timepoint: During hysteroscopy. Method of measurement: Ask from patient.